Quest Diagnostics (DGX) EPS (2009 - 2026)
Quest Diagnostics (DGX) EPS from Jun 30, 2009 to Mar 31, 2026. The TTM Quest Diagnostics (DGX) EPS is $8.98. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Quest Diagnostics (DGX) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +15.39% |
| 3 Years TTM | +5.19% |
| 5 Years TTM | -5.15% |
| 10 Years TTM | +6.00% |
| All Time TTM | +5.46% |
Annual EPS change of Quest Diagnostics (DGX)
| Year | EPS | Change |
|---|---|---|
| 2026 | $2.29 | -74.37% |
| 2025 | $8.94 | +13.89% |
| 2024 | $7.85 | +2.91% |
| 2023 | $7.63 | -6.50% |
| 2022 | $8.16 | -48.90% |
| 2021 | $15.96 | +49.45% |
| 2020 | $10.68 | +66.78% |
| 2019 | $6.40 | +18.32% |
| 2018 | $5.41 | -3.96% |
| 2017 | $5.64 | +22.31% |
| 2016 | $4.61 | -6.43% |
| 2015 | $4.92 | +28.40% |
| 2014 | $3.83 | -31.35% |
| 2013 | $5.59 | +59.73% |
| 2012 | $3.50 | +18.05% |
| 2011 | $2.96 | -27.81% |
| 2010 | $4.10 | +4.65% |
| 2009 | $3.92 | +31.01% |
| 2008 | $2.99 | N/A |
Comparison Quest Diagnostics (DGX) five years EPS CAGR with competitors
Quest Diagnostics (DGX) five years EPS CAGR is 8.13%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| NOTV | Inotiv Inc | 62.28% | +666.26% |
| IQV | IQVIA Holdings Inc | 30.82% | +279.14% |
| MEDP | Medpace Holdings Inc | 29.42% | +262.00% |
| WAT | Waters Corp | 15.00% | +84.54% |
| TMO | Thermo Fisher Scientific Inc | 14.94% | +83.76% |
| IDXX | Idexx Laboratories Inc | 11.68% | +43.64% |
| A | Agilent Technologies Inc | 11.51% | +41.59% |
| MTD | Mettler-Toledo International Inc | 10.58% | +30.13% |
| QGEN | Qiagen NV | 3.15% | -61.19% |
| GH | Guardant Health Inc | 1.05% | -87.13% |